Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...

New research from the IU School of Medicine found a discovery that could lead to new treatments for prostate cancer. The American Cancer Society said one in eight men will be ...

Welcome to Fierce Pharma's regulatory tracker for the first half of 2025. | In this tracker, Fierce Pharma is recording the ...

The University of Mississippi Medical Center Cancer Center and Research Institute received a $1.4 million grant from the U.S.

We conducted a narrative review of clinical trials focused on GU malignancy (prostate ... assess treatment burden across key domains including financial, time and travel, and medication management.

Postmenopausal Hormone Replacement Therapy and Breast Cancer. MedGenMed 2(4), 2000. [formerly published in Medscape Women's Health eJournal 5(4), 2000]. Available at: https://www.medscape.com ...

Compared to white men, Black men are at greater risk of prostate cancer, more likely to develop it earlier, and more likely to die from it. Earlier screening may be warranted. Dr. Sheel Patel ...

Menopause has long been a hush-hush topic, something on the periphery of our minds that no one really wants to talk about. (Except maybe in hushed whispers with your best friend while fanning ...

Prostate cancer is a leading cause of cancer deaths in American men. Current treatments target the hormone testosterone, which prostate cancer cells need to grow. Unfortunately, prostate tumors ...

This gap was especially pronounced in cancers with higher survival rates, such as prostate and breast cancer ... treatments in underserved communities, we can significantly improve life expectancy ...